All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

58

Reset

58 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • NSC001Phase 21 trial

    NSC-Therapeutics · Alzheimer Disease

  • NTRX-07MDA7Phase 21 trial

    NeuroTherapia, Inc. · Alzheimer Disease, Mild Cognitive Impairment

  • PRI-002ContraloidPhase 21 trial

    PRInnovation GmbH · Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease, Early Onset

  • RO7269162Phase 21 trial

    Roche (Genentech) · Alzheimer's Disease

  • sabirnetugPhase 21 trial

    Acumen Pharmaceuticals · Alzheimer Disease

  • SAR448851Phase 21 trial

    Sanofi · Dementia, Alzheimer's Type, Alzheimer's Disease

  • VY7523Phase 21 trial

    Voyager Therapeutics · Alzheimer's Disease (AD)

  • XPro1595INB03, XProPhase 21 trial

    Inmune Bio, Inc. · Alzheimer Disease, Dementia, Brain Diseases

NewerPage 2 of 2

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.